MoonLake Historical Financial Ratios

MLTX Stock  USD 55.30  0.00  0.00%   
MoonLake Immunotherapeuti is lately reporting on over 96 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate MoonLake Immunotherapeuti financial condition quickly.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MoonLake Immunotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About MoonLake Financial Ratios Analysis

MoonLake ImmunotherapeutiFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate MoonLake Immunotherapeuti investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on MoonLake financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across MoonLake Immunotherapeuti history.

MoonLake Immunotherapeuti Financial Ratios Chart

At this time, MoonLake Immunotherapeuti's Ebt Per Ebit is fairly stable compared to the past year. Quick Ratio is likely to rise to 54.17 in 2024, whereas Free Cash Flow Yield is likely to drop (0.02) in 2024.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Payout Ratio

Payout Ratio is the proportion of MoonLake Immunotherapeutics earnings paid out as dividends to shareholders. Payout Ratio is typically expressed as a percentage but can be shown as dividends paid out as a proportion of cash flow. The payout ratio is used to determine the sustainability of MoonLake Immunotherapeuti dividend payments. A lower payout ratio is generally preferable to a higher payout ratio, with a ratio greater than 100% indicating MoonLake Immunotherapeuti is paying out more in dividends than it makes in net income.

Asset Turnover

The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.
Most ratios from MoonLake Immunotherapeuti's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into MoonLake Immunotherapeuti current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MoonLake Immunotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
At this time, MoonLake Immunotherapeuti's Ebt Per Ebit is fairly stable compared to the past year. Quick Ratio is likely to rise to 54.17 in 2024, whereas Free Cash Flow Yield is likely to drop (0.02) in 2024.
 2010 2023 2024 (projected)
Payables Turnover0.0040310.230.25
Days Of Inventory On Hand97.1K87.4K77.7K

MoonLake Immunotherapeuti fundamentals Correlations

0.630.570.430.291.00.430.74-0.540.55-0.540.730.590.18-0.480.18-0.73-0.12-0.850.180.210.710.180.630.020.68
0.630.90.80.620.630.80.82-0.480.84-0.480.120.38-0.38-0.55-0.38-0.150.43-0.64-0.37-0.330.85-0.370.890.630.67
0.570.90.980.230.570.980.95-0.10.99-0.1-0.12-0.01-0.67-0.15-0.670.10.71-0.79-0.66-0.630.97-0.661.00.830.31
0.430.80.980.050.431.00.920.110.990.11-0.29-0.22-0.80.06-0.80.280.83-0.76-0.8-0.780.94-0.790.970.90.11
0.290.620.230.050.290.050.09-0.850.1-0.850.380.80.27-0.950.27-0.41-0.230.080.280.320.120.290.2-0.010.88
1.00.630.570.430.290.430.74-0.540.55-0.540.730.590.18-0.480.18-0.73-0.12-0.850.180.210.710.180.630.020.68
0.430.80.981.00.050.430.920.110.990.11-0.29-0.22-0.80.06-0.80.290.83-0.76-0.8-0.780.94-0.80.970.90.1
0.740.820.950.920.090.740.92-0.10.97-0.10.080.04-0.53-0.1-0.53-0.080.58-0.94-0.53-0.51.0-0.530.980.680.32
-0.54-0.48-0.10.11-0.85-0.540.11-0.10.011.0-0.72-0.94-0.550.92-0.550.740.470.08-0.56-0.59-0.1-0.56-0.10.33-0.93
0.550.840.990.990.10.550.990.970.010.01-0.16-0.11-0.71-0.03-0.710.150.75-0.83-0.71-0.680.98-0.710.990.840.21
-0.54-0.48-0.10.11-0.85-0.540.11-0.11.00.01-0.72-0.94-0.550.92-0.550.740.470.08-0.56-0.59-0.1-0.56-0.10.33-0.93
0.730.12-0.12-0.290.380.73-0.290.08-0.72-0.16-0.720.850.8-0.640.8-1.0-0.76-0.290.810.820.030.81-0.06-0.650.72
0.590.38-0.01-0.220.80.59-0.220.04-0.94-0.11-0.940.850.7-0.940.71-0.87-0.66-0.080.710.740.030.710.01-0.460.94
0.18-0.38-0.67-0.80.270.18-0.8-0.53-0.55-0.71-0.550.80.7-0.491.0-0.8-0.990.321.01.0-0.571.0-0.63-0.950.43
-0.48-0.55-0.150.06-0.95-0.480.06-0.10.92-0.030.92-0.64-0.94-0.49-0.490.670.450.03-0.5-0.54-0.11-0.5-0.140.22-0.97
0.18-0.38-0.67-0.80.270.18-0.8-0.53-0.55-0.71-0.550.80.711.0-0.49-0.8-0.990.321.01.0-0.571.0-0.63-0.950.43
-0.73-0.150.10.28-0.41-0.730.29-0.080.740.150.74-1.0-0.87-0.80.67-0.80.760.29-0.8-0.82-0.04-0.810.050.64-0.74
-0.120.430.710.83-0.23-0.120.830.580.470.750.47-0.76-0.66-0.990.45-0.990.76-0.36-0.99-0.990.61-0.990.670.95-0.37
-0.85-0.64-0.79-0.760.08-0.85-0.76-0.940.08-0.830.08-0.29-0.080.320.030.320.29-0.360.310.3-0.910.31-0.84-0.42-0.28
0.18-0.37-0.66-0.80.280.18-0.8-0.53-0.56-0.71-0.560.810.711.0-0.51.0-0.8-0.990.311.0-0.561.0-0.62-0.950.44
0.21-0.33-0.63-0.780.320.21-0.78-0.5-0.59-0.68-0.590.820.741.0-0.541.0-0.82-0.990.31.0-0.541.0-0.6-0.940.47
0.710.850.970.940.120.710.941.0-0.10.98-0.10.030.03-0.57-0.11-0.57-0.040.61-0.91-0.56-0.54-0.560.990.720.32
0.18-0.37-0.66-0.790.290.18-0.8-0.53-0.56-0.71-0.560.810.711.0-0.51.0-0.81-0.990.311.01.0-0.56-0.62-0.950.44
0.630.891.00.970.20.630.970.98-0.10.99-0.1-0.060.01-0.63-0.14-0.630.050.67-0.84-0.62-0.60.99-0.620.790.32
0.020.630.830.9-0.010.020.90.680.330.840.33-0.65-0.46-0.950.22-0.950.640.95-0.42-0.95-0.940.72-0.950.79-0.14
0.680.670.310.110.880.680.10.32-0.930.21-0.930.720.940.43-0.970.43-0.74-0.37-0.280.440.470.320.440.32-0.14
Click cells to compare fundamentals

MoonLake Immunotherapeuti Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MoonLake Stock Analysis

When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.